Back
ESC Premium Access

Patient characteristics and treatment patterns in patients on lipid-lowering therapies following an acute coronary syndrome in France

Session: Poster Session 1 - Lipids
Topic: Secondary Prevention
Speaker: Professor E. Bruckert (Paris, FR)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Professor Eric Bruckert

University Pierre & Marie Curie Paris VI, Paris (France)
4 presentations
0 follower

14 more presentations in this session

What is the most important residual risk after achievement of appropriate low-density lipoprotein cholesterol lowering therapy in secondary prevention of Japanese patients?

Speaker: Doctor A. Endo (Izumo, JP)

Access
Abstract
Like
Thumbnail

Association of adherence and treatment intensity of lipid-lowering therapy with cardiovascular outcomes and all-cause mortality in very high-risk patients in Germany

Speaker: Professor I. Ahrens (Cologne, DE)

Access
Abstract
Like
Thumbnail

Relative fat mass (RFM) is a better predictor of dyslipidemia and metabolic syndrome than body mass index (BMI).

Speaker: Doctor O. Kobo (Hadera, IL)

Access
Abstract
Slides
Like
Thumbnail

Low levels of low density lipoprotein cholesterol and cardiovascular, cancer and all-cause mortality outcomes

Speaker: Professor K. Sung (Seoul, KR)

Access
Abstract
Like
Thumbnail

Effects of personalized therapy-effect predictions on statin treatment decisions by patients and physicians: a three-armed, blinded, randomized controlled trial

Speaker: Ms N. Jaspers (Utrecht, NL)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 1 - Lipids

Speakers: Professor E. Bruckert, Doctor A. Endo, Professor I. Ahrens, Doctor O. Kobo, Professor K. Sung...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources